Cel Sci Quick Ratio (CVM) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Cel sci Corporation  (NYSE: CVM)

Cel Sci's Quick Ratio

CVM's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2026, Quick Ratio fell to 0 a new company low.

Within Biotechnology & Pharmaceuticals industry 144 other companies have achieved higher Quick Ratio than Cel Sci in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 3827 to 4514.

Explain Quick Ratio?
How much Cash & cash equivalents CVM´s has?
What are CVM´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CVM Quick Ratio (Jun 30 2026)
Q3		 (Mar 31 2026)
Q2		 (Dec 31 2025)
Q1		 (Sep 30 2025)
Q4		 (Jun 30 2025)
Q3
Y / Y Current Liabilities Change -9.55 % -12.58 % 11.15 % 11.15 % 1.99 %
Y / Y Cash & cash equivalent Change 4.07 % 4.07 % 102.43 % 102.43 % -85.33 %
Quick Ratio MRQ 0 0 0 0 0
CVM's Total Ranking # 4514 # 3827 # 4396 # 4052 # 3878
Seq. Current Liabilities Change 5.65 % -6.29 % 0 % -8.64 % 2.11 %
Seq. Cash & cash equivalent Change 0 % 10.16 % 0 % -5.53 % 0 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 145
Healthcare Sector # 924
Overall Market # 4514


Quick Ratio Statistics
High Average Low
11.7 2.86 0
(Sep 30 2010)   (Dec 31 2024)




Financial Statements
Cel Sci's Current Liabilities $ 5 Millions Visit CVM's Balance sheet
Cel Sci's Cash & cash equivalent $ 0 Millions Visit CVM's Balance sheet
Source of CVM's Sales Visit CVM's Sales by Geography


Cumulative Cel Sci's Quick Ratio

CVM's Quick Ratio for the trailling 12 Months

CVM Quick Ratio

 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth -0.98 % 2.21 % 7.83 % 0.32 % -6.51 %
Y / Y Cash & cash equivalent TTM Growth 35.36 % -55.09 % -98.77 % -98.92 % -99.08 %
Quick Ratio TTM 0 0 0 0 0
Total Ranking TTM # 4228 # 2962 # 3168 # 3331 # 3244
Seq. Current Liabilities TTM Growth -2.59 % -3.24 % 2.47 % 2.53 % 0.54 %
Seq. Cash & cash equivalent TTM Growth 1.03 % 1.05 % 14.01 % 16.3 % -66.48 %

Quick ratio ranking by company, industry and sector >> Back to CVM Financial Strength Comparisons >> Go to Compare CVM Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in CVM's Current Liabilities to $5.08 millions, cumulative Quick Ratio